Predicting risk of febrile neutropenia after CHOP chemotherapy.

被引：0
|
作者：
Chawla, RK [1 ]
Tompkins, KA [1 ]
Borgaonkar, MR [1 ]
Duggan, PR [1 ]
机构：
[1] Mem Univ Newfoundland, St John, NF A1C 5S7, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4585
引用
收藏
页码：230B / 230B
页数：1
相关论文
共 50 条
  • [1] Risk of febrile neutropenia among patients receiving CHOP chemotherapy.
    Lyman, GH
    Dale, DC
    Crawford, J
    Stolshek, B
    Carter, W
    Delgado, D
    BLOOD, 2001, 98 (11) : 230B - 231B
  • [2] Ceftriaxone monotherapy in "low risk" febrile neutropenia during cancer chemotherapy.
    Magne, N
    Chamorey, E
    Foa, C
    Otto, J
    Bernard-Thiery, I
    Thyss, A
    ANNALS OF ONCOLOGY, 2000, 11 : 150 - 150
  • [3] LYMPHOPENIA PREDICT FOR THE RISK OF FEBRILE NEUTROPENIA AFTER CHEMOTHERAPY
    Kacem, K.
    Ben Nasr, S.
    Zriba, S.
    Ben Lakhal, R.
    Yahyaoui, Y.
    El Benna, H.
    Zarrouk, M.
    Ben Amor, R.
    Ben Abdennebi, Y.
    Ben Neji, H.
    Jeddi, R.
    Ali, Z. Bel Hadj
    Ben Abid, H.
    Meddeb, B.
    HAEMATOLOGICA, 2012, 97 : 662 - 662
  • [4] Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia
    Dubos, Francois
    Delebarre, Mathilde
    Martinot, Alain
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (01) : 39 - 43
  • [5] Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient setting
    Usami, Eiseki
    Kimura, Michio
    Iwai, Mina
    Takenaka, Shoya
    Teramachi, Hifomi
    Yoshimura, Tomoaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 591 - 596
  • [6] Oncological emergencies in chemotherapy. Febrile neutropenia, tumor lysis syndrome, and extravasation
    von Amsberg, G.
    UROLOGE, 2018, 57 (05): : 552 - 557
  • [7] Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
    I Ray-Coquard
    C Borg
    Th Bachelot
    C Sebban
    I Philip
    G Clapisson
    A Le Cesne
    P Biron
    F Chauvin
    J Y Blay
    British Journal of Cancer, 2003, 88 : 181 - 186
  • [8] Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia
    Blay, JY
    Chauvin, F
    LeCesne, A
    Anglaret, B
    Bouhour, D
    Lasset, C
    Freyer, G
    Philip, T
    Biron, P
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 636 - 643
  • [9] Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
    Ray-Coquard, I
    Borg, C
    Bachelot, T
    Sebban, C
    Philip, I
    Clapisson, G
    Le Cesne, A
    Biron, P
    Chauvin, F
    Blay, JY
    BRITISH JOURNAL OF CANCER, 2003, 88 (02) : 181 - 186
  • [10] Thrombocytopenia As a Risk Factor for Developing Febrile Neutropenia in Patients with DLBCL Receiving R-CHOP Chemotherapy
    Bailey, Ryan Edward
    Bliven, Sean Patrick
    Narkhede, Mayur
    BLOOD, 2022, 140 : 12122 - 12124
12345